Short Bowel Syndrome Market Competitive Landscape And Forecast 2022-2028
The Short Bowel Syndrome Market was characterized by intense competition and significant research and development activities. Key pharmaceutical companies and biotech firms were striving to gain a competitive edge in this niche market segment. Some of the prominent players in the SBS market included Shire (a Takeda company), Zealand Pharma, OxThera, and Emmaus Life Sciences. These companies...
0 Comments 0 Shares 1393 Views 0 Reviews
Sponsored